Bridgefront Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,953
Closed -$369K 747
2026
Q1
$369K Buy
+1,953
New +$411K 0.09% 337
2025
Q3
Sell
-1,530
Closed -$269K 832
2025
Q2
$269K Sell
1,530
-3,060
-67% -$461K 0.07% 462
2025
Q1
$617K Buy
+4,590
New +$604K 0.18% 196
2024
Q3
Sell
-3,268
Closed -$435K 710
2024
Q2
$435K Buy
+3,268
New +$393K 0.18% 195
2022
Q3
Sell
-3,824
Closed -$201K 461
2022
Q2
$201K Buy
+3,824
New +$266K 0.22% 232
2021
Q2
Sell
-3,940
Closed -$205K 901
2021
Q1
$205K Buy
+3,940
New +$199K 0.06% 582

Other funds holding THC

Bridgefront Capital's THC Position: Q2 2026 in Review

Bridgefront Capital sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,953 shares — an estimated $369K sold.

Bridgefront Capital first reported a position in THC in Q1 2021 and held it in 6 quarters. The position peaked at $617K in Q1 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Bridgefront Capital reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 1,953 Tenet Healthcare shares in Q2 2026, an estimated $369K.
  • Bridgefront Capital first reported a position in Tenet Healthcare in Q1 2021 and held it in 6 quarters.
  • Bridgefront Capital's Tenet Healthcare position peaked at $617K in Q1 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.